Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tur-Kaspa

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|May 25, 1987
The effects of dexamethasone on in vitro collagen gene expressionF R Weiner, M J Czaja, D M Jefferson, et al.
Harefuah|May 15, 1997
[Liver allografts from donors older than 60: benefits and risks]E Mor, D Shmueli, Z Ben-Ari, et al.
Transplantation Proceedings|March 20, 2003
Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantationE Mor, M Brown, R Michowiz, et al.
Blood|October 7, 2000
Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type IIY Kitay-Cohen, A Amiel, N Hilzenrat, et al.
Journal of Viral Hepatitis|March 27, 2001
Cell transformation induced by hepatitis C virus NS3 serine proteaseR Zemel, S Gerechet, H Greif, et al.
Transplantation Proceedings|September 18, 1997
Hepatitis HGV/GBV-C viremia in renal transplant recipientsS Lustig, R Zemel, R Dickman, et al.
Transplantation Proceedings|November 20, 1997
A 4-year small-center experience in liver transplantationD Shmueli, E Mor, E Sharabani, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 9, 2004
Role of circulating soluble CD40 as an apoptotic marker in liver diseaseH Schmilovitz-Weiss, A Belinki, O Pappo, et al.
Journal of Viral Hepatitis|January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activityL Bachmetov, M Gal-Tanamy, A Shapira, et al.
Journal of Internal Medicine|July 16, 2003
Circulating soluble cytochrome c in liver disease as a marker of apoptosisZ Ben-Ari, H Schmilovotz-Weiss, A Belinki, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|May 25, 1987
The effects of dexamethasone on in vitro collagen gene expressionF R Weiner, M J Czaja, D M Jefferson, et al.
Harefuah|May 15, 1997
[Liver allografts from donors older than 60: benefits and risks]E Mor, D Shmueli, Z Ben-Ari, et al.
Transplantation Proceedings|March 20, 2003
Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantationE Mor, M Brown, R Michowiz, et al.
Blood|October 7, 2000
Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type IIY Kitay-Cohen, A Amiel, N Hilzenrat, et al.
Journal of Viral Hepatitis|March 27, 2001
Cell transformation induced by hepatitis C virus NS3 serine proteaseR Zemel, S Gerechet, H Greif, et al.
Transplantation Proceedings|September 18, 1997
Hepatitis HGV/GBV-C viremia in renal transplant recipientsS Lustig, R Zemel, R Dickman, et al.
Transplantation Proceedings|November 20, 1997
A 4-year small-center experience in liver transplantationD Shmueli, E Mor, E Sharabani, et al.
Apoptosis : an International Journal on Programmed Cell Death|March 9, 2004
Role of circulating soluble CD40 as an apoptotic marker in liver diseaseH Schmilovitz-Weiss, A Belinki, O Pappo, et al.
Journal of Viral Hepatitis|January 14, 2012
Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activityL Bachmetov, M Gal-Tanamy, A Shapira, et al.
Journal of Internal Medicine|July 16, 2003
Circulating soluble cytochrome c in liver disease as a marker of apoptosisZ Ben-Ari, H Schmilovotz-Weiss, A Belinki, et al.
Pageof 15